Genome-wide analysis of haploinsufficiency in human embryonic stem cells

Cell Rep. 2022 Mar 29;38(13):110573. doi: 10.1016/j.celrep.2022.110573.

Abstract

Haploinsufficiency describes a phenomenon where one functioning allele is insufficient for a normal phenotype, underlying several human diseases. The effect of haploinsufficiency on human embryonic stem cells (hESC) has not been thoroughly studied. To establish a genome-wide loss-of-function screening for heterozygous mutations, we fuse normal haploid hESCs with a library of mutant haploid hESCs. We identify over 600 genes with a negative effect on hESC growth in a haploinsufficient manner and characterize them as genes showing less tolerance to mutations, conservation during evolution, and depletion from telomeres and X chromosome. Interestingly, a large fraction of these genes is associated with extracellular matrix and plasma membrane and enriched for genes within WNT and TGF-β pathways. We thus identify haploinsufficiency-related genes that show growth retardation in early embryonic cells, suggesting dosage-dependent phenotypes in hESCs. Overall, we construct a unique model for studying haploinsufficiency and identified important dosage-dependent pathways involved in hESC growth and survival.

Keywords: CP: Cell Biology; CP: Stem Cell Research; essential genes; genetic screening; haploinsufficiency; human embryonic stem cells; signaling pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Haploidy
  • Haploinsufficiency / genetics
  • Heterozygote
  • Human Embryonic Stem Cells*
  • Humans